| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 85 |
| 1 | ESOMEPRAZOLE MAGNESIUM | 52 |
| 2 | ASPIRIN | 44 |
| 3 | ASPIRIN 325 MG | 43 |
| 4 | ASPIRIN 81 MG | 43 |
| 5 | DROSPIRENONE AND ETHINYL ESTRADIOL | 43 |
| 6 | OLMESARTAN MEDOXOMIL | 41 |
| 7 | PREDNISONE | 39 |
| 8 | METHOTREXATE SODIUM | 35 |
| 9 | METHOTREXATE | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPIDERMAL GROWTH FACTOR | 1 | 0.1667 |
| 1 | RUTIN | 1 | 0.0112 |
| 2 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 3 | PRAZIQUANTEL | 1 | 0.0033 |
| 4 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 3 | 0.0033 |
| 5 | VALERIAN | 2 | 0.0028 |
| 6 | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | 19 | 0.0026 |
| 7 | AMIFOSTINE | 2 | 0.0025 |
| 8 | RIZATRIPTAN BENZOATE | 23 | 0.0022 |
| 9 | ALOGLIPTIN | 6 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 110 |
| 1 | Corticosteroid [EPC] | 68 |
| 2 | Proton Pump Inhibitor [EPC] | 67 |
| 3 | Benzodiazepine [EPC] | 65 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 48 |
| 5 | Vitamin C [EPC] | 45 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 44 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 37 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 34 |
| 9 | Integrin Receptor Antagonist [EPC] | 34 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 2 | 0.0010 |
| 2 | Provitamin D2 Compound [EPC] | 25 | 0.0008 |
| 3 | Sodium Channel Blocker [EPC] | 1 | 0.0006 |
| 4 | Muscle Relaxant [EPC] | 28 | 0.0006 |
| 5 | Human Immunoglobulin G [EPC] | 12 | 0.0006 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 7 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 8 | Neurokinin 3 Receptor Antagonist [EPC] | 1 | 0.0004 |
| 9 | Ergot Derivative [EPC] | 2 | 0.0004 |